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Take-Home Message 
Nutrition and immune function are inextricably linked, and only through a better understanding 
of their reciprocal relationship can we hope to develop novel approaches to improve health and 
productivity of livestock species. Activation of the immune system elicits a cascade of metabolic, 
neuroendocrine, and behavioral events that have direct implications on feeding behavior and 
rates of lean tissue accretion. Nutritional intervention may constitute a cost-effective means by 
which to alter immune function, including the incidence, severity, and duration of sickness. 
Immunological Stress Responses 
Immunological stress is characterized by a reduction in voluntary feed intake and animal 
productivity (i.e., growth), which is largely due to a repartitioning of nutrients away from skeletal 
muscle accretion and toward metabolic responses that support the immune system (Johnson, 
1997; Klasing and Johnstone, 1991; Spurlock, 1997). Early evidence that immune activation 
negatively affects protein accretion rates of livestock species was provided through an elegant 
series of experiments in broiler chicks, where 70% of the reduction in body weight gain was 
linked directly to reduced feed intake (Klasing, 1984; Klasing and Barnes, 1988; Klasing et al., 
1987). Similar conclusions can be drawn from studies conducted in an applied swine production 
setting when comparing high and low health status situations. When no vaccines or antibiotics 
were administered and the facility remained in a 'dirty' state, pigs exhibited a decreased rate in 
whole body protein accretion, which translated into a 20% reduction in the dietary lysine 
requirement (expressed as% of diet) and a 40% reduction in daily lysine intake (Williams et al., 
1997). Obviously, these findings translate into increased costs and lost profits for livestock 
producers. 
A substantial body of evidence suggests the collective set of metabolic, neuroendocrine, and 
behavioral events that occur during immunological stress is largely driven by the production and 
release of specialized proteins known as cytokines, including tumor necrosis factor-alpha 
(TNFa), interleukin (IL) 1-beta (IL-113), and IL-6. When an animal's innate immune system is 
activated through recognition of a pathogen, proinflammatory cytokines are produced acutely by 
peripheral leukocytes (e.g., monocytes and macrophages). These cytokines also serve as a 
major route to transmit information to the brain that an infection has occurred. More complex 
routes of peripheral-to-central communication are also known to exist, and the reader is 
encouraged to peruse seminal reviews that have been written on the subject (Blalock, 1994; 
Quan and Banks, 2007). Whether produced by peripheral leukocytes or by resident microglial 
cells directly in the central nervous, proinflammatory cytokines have a profound ability to induce 
central adaptive responses designed to restore homeorhesis and get the animal back to a 
'healthy' phenotype following an infection. 
Collectively referred to as 'sickness behavior', the non-specific symptoms of an activated 
immune system include fever, fatigue, disruption of sleep patterns, social isolation, decreased 
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feed and water intake, and body weight loss (Kelley et al., 2003). Whereas the obvious 
phenotypic signs of infection may be evident to a livestock producer, it is the underlying 
metabolic shifts that are most important to understand. A major reprioritization of nutrients 
occurs during an acute infection, with maintenance of the immune system becoming a higher 
priority than growth, and this translates into a reduced availability of dietary nutrients for muscle 
protein accretion. Importantly, cytokines can independently and simultaneously affect both 
synthesis and degradation of protein in tissues, and thus, cytokines are responsible for adjusting 
animal growth rates based on the level of immunological challenge. Also important is the fact 
that proinflammatory cytokines are manifest in both central and peripheral compartments, and 
these effects are what ultimately drive the phenotypic responses observed during sickness. For 
example, the febrile response harnesses metabolic inefficiency to produce heat by increasing 
the metabolic rate 13% for every degree Celsius increase in core body temperature (Kluger, 
1991 ). Additionally, the production of cytokines and development of immune cells require 
significant nutrient resources, most notably in the form of amino acids, to allow the animal to 
mount an effective immune response. The consequence of nutrient repartitioning as a result of 
immune activation is that dietary nutrient requirements and efficiency of utilization are altered, 
and this has direct implications for animal nutritionists. 
From a livestock production perspective, a drastic decrease in voluntary feed intake and loss of 
body weight, especially of skeletal muscle mass, are particularly important consequences of 
immunologic stress. Acute immune activation results in increased whole-body protein turnover, 
with a decreased rate of protein synthesis and increased rate of protein degradation, but 
responses differ by peripheral tissue. Considering skeletal muscle represents 40-45% of body 
mass, this tissue represents the largest labile pool of amino acids. Dietary amino acid 
requirements are decreased in immunologically-challenged animals, suggesting that decreased 
muscle accretion and an overall slower growth rate spare essential amino acids for use in 
anabolic processes that occur primarily in the liver and immune cells. In essence, protein 
degradation of skeletal muscle during innate immune activation increases the supply of amino 
acids for acute phase protein synthesis in the liver (Spurlock, 1997). It has been estimated that 
contributions of the liver to whole body protein synthesis increase from 15% to 33% during 
acute immune stimulation (Breuille et al., 1998), as accompanied by increased hepatic uptake of 
amino acids (Humphrey and Klasing, 2005). The combination of reduced feed intake, increased 
hepatic acute phase protein synthesis, and disparity in amino acid composition between skeletal 
muscle and acute phase proteins ultimately results in greater body protein losses in 
immunologically-challenged animals than can be explained by reduced feed intake alone 
(Reeds et al., 1994). Considering amino acids in excess of physiological requirements cannot 
be stored, greater rates of amino acid oxidation are also evident during immune activation. 
Quantitation of amino acid requirements for development, maintenance, and use of the immune 
system clearly shows the greatest quantitative need is for acute phase protein synthesis and 
activation of oxidative defenses (Klasing and Calvert, 1999). Using a direct approach, work with 
broiler chicks suggested that development and maintenance of immune function accounts for no 
more than 2% of the total lysine requirement, while use of lysine during an acute infection may 
consume 7-10% of the total requirement as part of liver hypertrophy and production of acute 
phase proteins (Klasing, 2007). Considering acute phase protein synthesis accounts for a 
significant proportion of total body protein synthesis during peak sickness, identification of 
amino acids that are enriched in these specialized proteins may help to guide nutritional 
strategies. Work by Reeds et al. (1994) suggested that acute phase proteins contained 
increased concentrations of aromatic amino acids (i.e., phenylalanine, tyrosine, and tryptophan) 
relative to skeletal muscle composition. Moreover, nearly all acute phase proteins are 
glycosylated and enriched in threonine, serine, aspartate, and asparagine, and cysteine may 
play a particularly important role as the limiting nutrient for synthesis of glutathione, a primary 
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antioxidant, during infection (Breuille et al., 2006). It should be noted that attempts to alter the 
immune response via supplementation of individual amino acids have largely been 
unsuccessful, but investigations into supplementation of amino acids combinations to 
immunologically-challenged animals are needed. 
Finding ways to manage both the magnitude and duration of an acute inflammatory response is 
key to maximizing productive performance and profitability. However, eliminating the 
proinflammatory response altogether is not feasible due to its integral role in host immune 
defenses. Complicating the matter further is evidence that genetic selection for growth potential 
may negatively affect the ability for animals to cope with an infection. By selecting for optimal 
production traits (e.g., lean tissue accretion), livestock species may have also been 
inadvertently selected to be more susceptible to pathogens (i.e., reduced immune robustness) 
or less able to maintain performance after infection (Clapperton et al., 2008; Flori et al., 2011; 
Qureshi and Havenstein, 1994 ). As sub-therapeutic antibiotic use is phased-out of disease 
preventative strategies, it may be necessary to alter genetic selection techniques to consider 
immune robustness along with production traits in production livestock species. From a 
nutritional perspective, however, there remain a number of mechanisms whereby nutrient intake 
can influence immunity and susceptibility to infectious diseases. 
As we gain a better understanding of how nutrition can play an immunomodulatory role, it is 
important to keep in mind that developing robust immunity is key. In general, managing sick 
animals should include delivery of nutrient profiles that support an appropriate level of immune 
reactivity while minimizing growth depression, and this must occur concomitantly with a 
reduction in voluntary feed intake. Evidence suggests certain nutrients can directly alter 
leukocyte proliferation rates, magnitude of cytokine production, differentiation of leukocyte 
populations, and even protect against cellular damage resulting from activated leukocytes 
(Klasing and Leshchinsky, 1999). Nutrients that fall into this category include polyunsaturated 
fatty acids, carotenoids and other specialized plant extracts, as well as vitamins A, D, and E. 
Antioxidant nutrients are also able to modulate immune function, due in part to their ability to 
protect against immunopathology via quenching of free radicals produced by leukocytes. 
Nutritional strategies designed to improve outcomes in animals experiencing immunological 
stress have often focused on feeding individual nutrients, but this is often met with highly 
variable responses. Further studies on how ingestion of specific nutrient(s) and bioactive 
compound(s) by pigs experiencing acute immune activation are warranted. 
Soybean Meal and the Viral Immune Response in Weanling Pigs 
Porcine reproductive and respiratory syndrome (PRRS), caused by the PRRS virus (PRRSV), is 
the most prevalent swine disease globally (Lunney et al., 2010), accounting for annual losses 
upwards of $665 million for US swine producers (Holtkamp et al., 2012; Neumann et al., 2005). 
Despite increased research focus and improved biosecurity measures, PRRS continues to pose 
a substantial financial burden for US swine producers. In parallel with pharmaceutical 
developments, there exists an impetus to better manage PRRSV-infected pigs, and nutrition 
may play an important role in this effort. Soybean meal (SBM) is the primary dietary source of 
crude protein and amino acids for swine in the US, and in addition to providing these nutrients, 
soybean feedstuffs also contain the isoflavones genistein, daidzein , and glycitein. Importantly, 
these plant-derived compounds are considered to have a range of biological activities, including 
antiviral effects, when included in an animal's diet (Andres et al., 2009). Greiner et al. (2001 a, b) 
evaluated graded concentrations of purified genistein and daidzein in diets of pigs infected with 
PRRSV and determined that while daidzein had minimal impact on immune function or growth 
of PRRSV-infected pigs, genistein at 200-400 mg/kg of diet elicited positive immunomodulatory 
effects and improved body weight gain. Thus, our laboratory sought to evaluate the effects of 
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SBM inclusion, which would concurrently increase both dietary crude protein and isoflavone 
concentrations, on immune and growth responses of pigs acutely infected with PRRSV. 
Four experimental treatments included a 2x2 
factorial arrangement of 2 dietary SBM 
concentrations, 17.5% (LSBM) and 29% 
(HSBM), and 2 levels of PRRSV infection, 
uninfected (sham) and PRRSV-infected. 
Weanling pigs (32 barrows and 32 gilts, 21 
days of age, 7.14 ± 0.54 kg) were individually 
housed in disease containment chambers. Pigs 
were provided a common diet for 1 week before 
being allotted to 4 treatment groups with 16 
replicate pigs per group. Pigs received 
experimental diets for 1 week before 
administration of either a sham inoculation 
( sterile PBS) or a 1 x 105 50% tissue culture 
infective dose of PRRSV at 35 days of age (0 
days post-inoculation, DPI). Growth 
performance was recorded weekly, and rectal 
temperatures were measured daily beginning 
on 0 DPI. Blood was collected on 0, 3, 7 and 14 
DPI for determination of differential complete 
blood cell counts, serum PRRSV load, and 
haptoglobin and cytokine concentrations. 
As a reliable measure of successful immune 
stimulation, PRRSV-infected pigs exhibited a 
mild febrile response, with increased (P < 0.01) 
rectal temperatures Oto 14 DPI, but there was 
no influence of dietary SBM concentration on 
this response (P > 0.05). In the PRRSV-infected 
group, pigs fed HSBM tended to have improved 
ADG (P = 0.06; Figure 1) and G:F (P = 0.09) 
compared with pigs fed LSBM. No effects of 
dietary SBM concentration on leukocyte 
measurements were observed within the 
PRRSV-infected group at any time point. Serum 
PRRSV load of PRRSV-infected pigs was lower 
(P < 0.05; Figure 2) in pigs fed HSBM 
compared with pigs fed LSBM at 14 DPI, but no 
differences were observed at 3 or 7 DPI ; this 
suggests that pigs receiving HSBM may have 
had an improved ability to eliminate the virus 
during the initial stages of recovery. Serum 
haptoglobin and tumor necrosis factor-a 
concentrations of PRRSV-infected pigs were 
greater (P < 0.05) at 3 and 14 DPI, respectively, 
ADG 0-14 DPI 
750 Infection x Diet: P = 0.04 [Z) LSBM 
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Figure 1. Average daily body weight gain of 
weanling pigs fed diets containing low (LSBM) 
or high (HSBM) concentrations of dietary 
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Figure 2. Serum PRRSV loads [expressed as 
raw cycle threshold (Ct) values] at 14 days post-
inoculation (DPI) from pigs fed diets containing 
low (LSBM) or high (HSBM) concentrations of 
dietary soybean meal. Note that a higher Ct value 
represents fewer PRRS viral particles being 
detected. ND= not detectable. 
in pigs fed LSBM compared with pigs fed HSBM; again, this indicates the potential for mild viral 
protective effects of SBM. Overall, it appears that the immunological stress elicited by PRRSV 
infection was decreased in pigs fed HSBM compared with pigs fed LSBM, which may have 
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contributed to the tendency for improved ADG and feed efficiency of the HSBM-fed pigs during 
the 14 day infection period. 
Considering the anti-inflammatory effects observed as a result of increased SBM concentration 
one is left wondering about the mechanism of action, and we have focused our attention on bot'h 
soy-derived bioactive compounds and greater CP delivered by the HSBM diet. Soybeans and 
soybean-derived feedstuffs are the richest sources of the isoflavones genistein, daidzein, and 
glycitein (Wang and Murphy, 1994 ), which are reported to exert both anti-inflammatory and anti-
viral activity through various mechanisms. A plethora of in vitro studies indicate that genistein 
may potentially inhibit virus-cell binding and entry, virus replication, viral protein translation, and 
viral envelope formation of a multitude of viruses (Andres et al., 2009). In our study, dietary 
genistein concentration of the LSBM diet (369 mg/kg) was within the range (200-400 mg/kg) 
suggested by Greiner et al. (2001 b) to have potential immunomodulatory and growth-enhancing 
effects on PRSSV-infected pigs, while genistein concentration of the HSBM diet (638 mg/kg) 
exceeded this range. Bioavailability of isoflavones is certainly influenced by the feed matrix 
(Cassidy et al., 2006), so it is entirely possible that the isoflavones contributed by SBM in the 
current study were less bioavailable than those provided in a supplemental, purified form by 
Greiner et al. (2001 a, b ). Further investigations to identify the mechanism by which SBM 
reduces immunological stress in PRSSV-infected weanling pigs are warranted. 
Acute Enterotoxigenic E. Coli Infection in Weanling Pigs 
Post-weaning diarrhea remains an important cause of mortality and morbidity in pigs weaned in 
the US swine industry, and enterotoxigenic Escherichia coli (ETEC) is a major cause of this 
illness. Whereas etiology of disease caused by ETEC is complex, it is strongly associated with 
structural and functional changes that occur in the intestine (Nagy and Fekete, 2005), and likely 
the immune system (Raetz and Whitfield, 2002), of newly-weaned pigs. Toxins produced by 
ETEC strains that ultimately lead to diarrhea include heat labile enterotoxin (LT), heat stable 
enterotoxin types A (STa) and B (STb), and Shiga toxin type 2e (Stx2e) (lmberechts et al., 
1997; Wilson and Francis, 1986). Pathogenic E. coli are categorized by 5 antigenically-distinct 
adhesins, all of which are fimbriae (also known as pili); F4 (K88), F5 (K99), F41, and F6 (987P) 
all mediate adhesion in neonatal piglets, while F18 is a common cause of post-weaning 
colibacillosis. Receptors for F18 fimbriae are not expressed in neonatal piglets, but are 
expressed in sufficient numbers to cause illness around the time of weaning (Nagy et al., 1992). 
Pathogenesis of ETEC begins with fimbriae-mediated adherence to specialized receptors 
located on microvilli of enterocytes, followed by colonization and production of enterotoxins, 
which subsequently elicit excessive secretion of fluids and electrolytes into the intestinal lumen. 
Approaches to control post-weaning ETEC diarrhea through improvements in management and 
environmental conditions, including prophylactic antibiotic use, have been largely ineffective. 
However, the requisite adherence of ETEC to mucosal receptors prior to colonization may allow 
for nutritional interventions to serve as alternative or complementary approaches to reducing 
incidence or severity of ETEC infection in weanling pigs. In our laboratory, we use an acute 
model of infection by orally-inoculating newly-weaned pigs with an F18-fimbriated ETEC 
isolated from a field disease outbreak (isolate number UI-VDL 05-27242). In brief, pigs are 
administered a 101° CFU/3 ml dose of ETEC once-daily for 3 consecutive days to cause mild-
to-moderate pathogenesis. Peak sickness in this model generally occurs 3-5 days after the 
initial ETEC inoculation, with symptoms subsiding or completely absent at 11 DPI. Over the 11-
day infective period, pigs generally experience a 35-40% decrease in average daily body weight 
gain and a concomitant increase in total leukocytes of nearly 40%. Moreover, both diarrhea 
score and frequency are increased in ETEC-inoculated pigs relative to sham-inoculated control 
animals. 
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Likely owing to a variety of mechanisms, research using this acute ETEC model has suggested 
that both hydrated aluminosilicates (i.e., dietary clays) (Almeida et al., 2013; Song et al., 2012) 
and purified plant extracts (Liu et al., 2013) are able to attenuate clinical symptoms in weaned 
pigs. Presumably, the dietary clay substrates are able to absorb and inactivate enterotoxins, or 
perhaps inhibit the growth of pathogenic E. coli, and secondary plant metabolites are able to 
directly or indirectly elicit immunomodulatory effects in pigs. Considering the incidence of F18 
ETEC is quite high not only in weanling pigs, but in human populations as well, there is great 
interest in identifying whether additional nutritional technologies can alleviate untoward effects 
of this type of infection. Gaining a more thorough understanding of the molecular mechanisms 
by which ETEC interacts with the host may provide meaningful insights to help combat this 
disease through dietary intervention. 
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